Polaris Group (TPE:6550)
36.10
-0.95 (-2.56%)
Apr 2, 2025, 1:35 PM CST
Polaris Group Revenue
In the year 2024, Polaris Group had annual revenue of 107.00M TWD with 1,330.29% growth. Polaris Group had revenue of 36.25M in the quarter ending December 31, 2024, with 639.87% growth.
Revenue
107.00M
Revenue Growth
+1,330.29%
P/S Ratio
258.68
Revenue / Employee
648.48K
Employees
165
Market Cap
27.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107.00M | 99.52M | 1,330.29% |
Dec 31, 2023 | 7.48M | 1.04M | 16.18% |
Dec 31, 2022 | 6.44M | -8.60M | -57.19% |
Dec 31, 2021 | 15.04M | 5.63M | 59.84% |
Dec 31, 2020 | 9.41M | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Center Laboratories | 1.62B |